Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Tert Butyl Sulfinamide. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108558715A details high-yield route. Reduces cost and environmental impact for pharmaceutical intermediates manufacturing significantly.
Discover CN101863805B technology for synthesizing chiral sulfinamide catalysts. Enables cost-effective, scalable production of high-purity pharmaceutical intermediates with superior enantioselectivity.
Patent CN109111380B introduces a transition-metal-free method for synthesizing chiral amines via hydrogen borrowing, offering cost reduction in API manufacturing and high stereoselectivity.
Patent CN101735118B details a silane-protected route for tert-butylsulfinamide, offering mild conditions and high purity for chiral amine synthesis.
Patent CN108409615B reveals a scalable method for enantiopure tert-butyl sulfinamide. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with this novel route.
Patent CN108409615B discloses a green route for chiral sulfinamides, eliminating liquid ammonia usage and enhancing yield for reliable pharmaceutical intermediate supply chains.